Stephen E. Gould is Chief Scientific Officer at Atreca, Inc. (BCEL). They have made 1 open-market trade across 1 company since 2023, most recently 2023-08-02.
CIK 0001934498
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCEL | 28,424 | $4K |
Shares reported on the most recent Form 4, priced at the 2023-08-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCEL | SELL | 2023-08-02 | 2023-08-04 | $0.95 | $4K | -59.8% | -63.4% | -77.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.